Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer
File version
Version of Record (VoR)
Author(s)
Li, Bin
Liang, Linhui
Xie, Jianjun
Xu, Wen Wen
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
Abstract
In this Research Topic, we collected 20 papers under the title of “Novel Molecular Targets and Treatments for gastroesophageal Cancer” (Das et al., Power et al., Heng et al., Islam et al., Wang et al., Li et al., Zhang et al., Zhang et al., Deng et al., Bai et al., Lv et al., Guo et al., Chen et al., Luan et al., Jiang et al., Jafarzadeh and Soltani, Jin et al., Fang et al., Wang et al., Chen et al.). Cancers of the oesophagus and stomach account for 8.7% of new cases and 13.2% of new deaths of all sites worldwide (1). In the World Health Organization (WHO) classification of tumours, oesophageal cancer has two major histological types, namely squamous cell carcinoma (SCC) and adenocarcinoma (2).
Journal Title
Frontiers in Oncology
Conference Title
Book Title
Edition
Volume
12
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2022 Lam, Li, Liang, Xie and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Item Access Status
Note
Access the data
Related item(s)
Subject
Oncology and carcinogenesis
Clinical sciences
Science & Technology
Life Sciences & Biomedicine
Oncology
esophagus
stomach
Persistent link to this record
Citation
Lam, AK-Y; Li, B; Liang, L; Xie, J; Xu, WW, Editorial: Novel Molecular Targets and Treatments for Gastroesophageal Cancer, Frontiers in Oncology, 2022, 12, pp. 888861